JAK3 抗体
(Janus Kinase 3 (JAK3))
The protein encoded by this gene is a member of the Janus kinase (JAK) family of tyrosine kinases involved in cytokine receptor-mediated intracellular signal transduction. It is predominantly expressed in immune cells and transduces a signal in response to its activation via tyrosine phosphorylation by interleukin receptors. Mutations in this gene are associated with autosomal SCID (severe combined immunodeficiency disease). [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| JAK3 抗体 (pTyr785) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| Recombinant JAK3 抗体 | 人 | 兔 Monoclonal |
|
|
|
| JAK3 抗体 (AA 517-749) | 小鼠 | 兔 Polyclonal |
|
|
|
| JAK3 抗体 (N-Term) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| JAK3 抗体 (Tyr785) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| JAK3 抗体 (AA 406-661) | 人 | 兔 Polyclonal |
|
|
|
| JAK3 抗体 (Tyr159) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| JAK3 抗体 (Middle Region) | 人, 小鼠, 大鼠, Cow, 犬, 马, Pig | 兔 Polyclonal |
|
|
|
| JAK3 抗体 (N-Term) | 人, 小鼠, 大鼠, Cow, 犬, 马, Pig, 豚鼠 | 兔 Polyclonal |
|
|
|
| JAK3 抗体 (AA 406-661) (APC) | 人 | 兔 Polyclonal |
|
|
|
| JAK3 抗体 | 人 | 兔 Monoclonal |
|
|
|
| JAK3 抗体 (AA 406-661) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| JAK3 抗体 (AA 406-661) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| JAK3 抗体 (AA 406-661) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| JAK3 抗体 (AA 406-661) (Fluoro550) | 人 | 兔 Polyclonal |
|
|
|
| JAK3 抗体 (AA 406-661) (Fluoro594) | 人 | 兔 Polyclonal |
|
|
|
| JAK3 抗体 (AA 406-661) | 人 | 兔 Polyclonal |
|
|
|
| JAK3 抗体 (AA 406-661) (Cy3) | 人 | 兔 Polyclonal |
|
|
|
| JAK3 抗体 (AA 406-661) (Fluoro488) | 人 | 兔 Polyclonal |
|
|
|
| JAK3 抗体 (AA 406-661) (Fluoro647) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pTyr785
Primary Antibody
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- R03-9I7R03-9I7
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 517-749
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 133-161, N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Tyr785
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 406-661
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Tyr159
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人, 小鼠, 大鼠, Cow, 犬, 马, Pig
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Middle Region
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人, 小鼠, 大鼠, Cow, 犬, 马, Pig, 豚鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- AA 406-661
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 406-661
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 406-661
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 406-661
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro550
- 抗体亚型
- IgG
- 抗原表位
- AA 406-661
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro594
- 抗体亚型
- IgG
- 抗原表位
- AA 406-661
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 406-661
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy3
- 抗体亚型
- IgG
- 抗原表位
- AA 406-661
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro488
- 抗体亚型
- IgG
- 抗原表位
- AA 406-661
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro647
- 抗体亚型
- IgG
- 抗原表位
- AA 406-661
Latest Publications for our JAK3 抗体
: "Combination of gemcitabine and erlotinib inhibits recurrent pancreatic cancer growth in mice via the JAK-STAT pathway." in: Oncology reports, Vol. 39, Issue 3, pp. 1081-1089, (2018) (PubMed).
: "Jak3 is involved in CCR7-dependent migration and invasion in metastatic squamous cell carcinoma of the head and neck." in: Oncology letters, Vol. 13, Issue 5, pp. 3191-3197, (2017) (PubMed).
: "Direct regulation of IL-2 by curcumin." in: Biochemical and biophysical research communications, Vol. 495, Issue 1, pp. 300-305, (2017) (PubMed).
: "JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin Diseases." in: PloS one, Vol. 11, Issue 10, pp. e0164080, (2017) (PubMed).
: "Novel compound heterozygous mutations in a Japanese girl with Janus kinase 3 deficiency." in: Pediatrics international : official journal of the Japan Pediatric Society, Vol. 58, Issue 10, pp. 1076-1080, (2016) (PubMed).
: "MSX3 Switches Microglia Polarization and Protects from Inflammation-Induced Demyelination." in: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 35, Issue 16, pp. 6350-65, (2015) (PubMed).
: "Jak3 expression and genomic sequence in pediatric acute lymphoblastic leukemia." in: Leukemia & lymphoma, Vol. 43, Issue 12, pp. 2355-62, (2003) (PubMed).
: "MAPKs: new JNK expands the group." in: Trends in biochemical sciences, Vol. 19, Issue 11, pp. 470-3, (1995) (PubMed).
: "Jak3 is involved in CCR7-dependent migration and invasion in metastatic squamous cell carcinoma of the head and neck." in: Oncology letters, Vol. 13, Issue 5, pp. 3191-3197, (2017) (PubMed).
: "Direct regulation of IL-2 by curcumin." in: Biochemical and biophysical research communications, Vol. 495, Issue 1, pp. 300-305, (2017) (PubMed).
: "JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin Diseases." in: PloS one, Vol. 11, Issue 10, pp. e0164080, (2017) (PubMed).
: "Novel compound heterozygous mutations in a Japanese girl with Janus kinase 3 deficiency." in: Pediatrics international : official journal of the Japan Pediatric Society, Vol. 58, Issue 10, pp. 1076-1080, (2016) (PubMed).
: "MSX3 Switches Microglia Polarization and Protects from Inflammation-Induced Demyelination." in: The Journal of neuroscience : the official journal of the Society for Neuroscience, Vol. 35, Issue 16, pp. 6350-65, (2015) (PubMed).
: "Jak3 expression and genomic sequence in pediatric acute lymphoblastic leukemia." in: Leukemia & lymphoma, Vol. 43, Issue 12, pp. 2355-62, (2003) (PubMed).
: "MAPKs: new JNK expands the group." in: Trends in biochemical sciences, Vol. 19, Issue 11, pp. 470-3, (1995) (PubMed).
Aliases for JAK3 抗体
Janus kinase 3 (JAK3) 抗体Janus kinase 3 (Jak3) 抗体
fae 抗体
JAK 抗体
JAK-3 抗体
JAK3_HUMAN 抗体
JAKL 抗体
L-JAK 抗体
LJAK 抗体
RATJAK3 抗体
wil 抗体
您还需要查找其他产品吗？
You are here:
